PledPharma AB (publ) Stock Nasdaq Stockholm
Equities
SE0003815604
Biotechnology & Medical Research
Sales 2024 * | 65.08M 5.99M | Sales 2025 * | 471M 43.33M | Capitalization | 1.73B 160M |
---|---|---|---|---|---|
Net income 2024 * | -291M -26.78M | Net income 2025 * | 105M 9.66M | EV / Sales 2024 * | 28.2 x |
Net Debt 2024 * | 103M 9.44M | Net cash position 2025 * | 61.97M 5.7M | EV / Sales 2025 * | 3.55 x |
P/E ratio 2024 * |
-6.24
x | P/E ratio 2025 * |
8.67
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 72.61% |
Latest transcript on PledPharma AB (publ)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 17-06-15 | |
Yilmaz Mahshid
DFI | Director of Finance/CFO | 45 | 17-12-30 |
Chief Tech/Sci/R&D Officer | - | 22-05-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mats Blom
BRD | Director/Board Member | 59 | 21-03-31 |
Director/Board Member | 50 | 19-12-31 | |
Thomas Lönngren
CHM | Chairman | 73 | 21-03-31 |
1st Jan change | Capi. | |
---|---|---|
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |